Literature DB >> 12709821

Whole-blood manganese levels and brain manganese accumulation in children receiving long-term home parenteral nutrition.

Yasushi Iinuma1, Masayuki Kubota, Masanori Uchiyama, Minoru Yagi, Satoshi Kanada, Satoru Yamazaki, Hiroki Murata, Kouichirou Okamoto, Masashi Suzuki, Kohjyu Nitta.   

Abstract

Recent reports attribute neurological and cerebral disorders to the accumulation of manganese (Mn) in the brain in patients receiving home parenteral nutrition (HPN). It is desirable to control the amount of Mn delivered to these patients, but a suitable method for monitoring an individual's Mn status and assessing Mn accumulation remains debatable. The aim of this study was to evaluate whether whole-blood manganese levels (WB-Mn) correlate with the accumulation of Mn in the brains of children who receive long-term HPN, using magnetic resonance imaging (MRI) of the brain. Six patients who had received HPN (duration of HPN, 18-137 months) were included in this study. The daily parenteral doses of Mn were calculated while on HPN. WB-Mn was measured and T1-weighted MRI of the brain was obtained for each patient with a 1.5-T MR imager. Twelve months after the withdrawal of Mn from HPN, measurements of WB-Mn and brain MRI were repeated in all patients except for one who was lost after initial examination. The same examinations were performed on an additional patient who had been successfully weaned off a 179 month course of HPN 20 months prior to the initial examination. The parenteral dose of Mn while receiving HPN ranged from 15.7 to 91.5 micro g/kg/day. Initially, MRI showed hyperintensity in the globus pallidus in all patients and in the anterior pituitary in one patient. WB-Mn was elevated in four patients, but was in the normal range in the remaining three. Following subsequent measurements 12 months later, WB-Mn was normal in all patients and MRI hyperintensity remained in the globus pallidus in one patient. One patient was lost after the initial examinations. WB-Mn does not necessarily correlate with the accumulation of Mn in the brain. Periodic MRI should be performed in patients receiving long-term NPN to monitor for excessive Mn accumulation in the brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709821     DOI: 10.1007/s00383-002-0929-6

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  22 in total

1.  On-off study of manganese administration to adult patients undergoing home parenteral nutrition: new indices of in vivo manganese level.

Authors:  Y Takagi; A Okada; K Sando; M Wasa; H Yoshida; N Hirabuki
Journal:  JPEN J Parenter Enteral Nutr       Date:  2001 Mar-Apr       Impact factor: 4.016

2.  Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition.

Authors:  S A Mirowitz; T J Westrich; J D Hirsch
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

3.  Manganese toxicity in children receiving long-term parenteral nutrition.

Authors:  J M Fell; A P Reynolds; N Meadows; K Khan; S G Long; G Quaghebeur; W J Taylor; P J Milla
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

4.  Longitudinal changes of manganese-dependent superoxide dismutase and other indexes of manganese and iron status in women.

Authors:  C D Davis; J L Greger
Journal:  Am J Clin Nutr       Date:  1992-03       Impact factor: 7.045

5.  Brain manganese deposition and blood levels in patients undergoing home parenteral nutrition.

Authors:  D B Bertinet; M Tinivella; F A Balzola; A de Francesco; O Davini; L Rizzo; P Massarenti; M A Leonardi; F Balzola
Journal:  JPEN J Parenter Enteral Nutr       Date:  2000 Jul-Aug       Impact factor: 4.016

6.  Manganese intoxication during intermittent parenteral nutrition: report of two cases.

Authors:  K Masumoto; S Suita; T Taguchi; T Yamanouchi; M Nagano; K Ogita; M Nakamura; F Mihara
Journal:  JPEN J Parenter Enteral Nutr       Date:  2001 Mar-Apr       Impact factor: 4.016

7.  Manganese deposition in the brain during long-term total parenteral nutrition.

Authors:  J Ono; K Harada; R Kodaka; K Sakurai; H Tajiri; Y Takagi; T Nagai; T Harada; A Nihei; A Okada
Journal:  JPEN J Parenter Enteral Nutr       Date:  1995 Jul-Aug       Impact factor: 4.016

8.  Manganese in long term paediatric parenteral nutrition.

Authors:  A P Reynolds; E Kiely; N Meadows
Journal:  Arch Dis Child       Date:  1994-12       Impact factor: 3.791

9.  Tissue manganese concentrations and antioxidant enzyme activities in rats given total parenteral nutrition with and without supplemental manganese.

Authors:  E A Malecki; H C Lo; H Yang; C D Davis; D M Ney; J L Greger
Journal:  JPEN J Parenter Enteral Nutr       Date:  1995 May-Jun       Impact factor: 4.016

Review 10.  A toxicologic risk for using manganese complexes? A literature survey of existing data through several medical specialties.

Authors:  B Misselwitz; A Mühler; H J Weinmann
Journal:  Invest Radiol       Date:  1995-10       Impact factor: 6.016

View more
  12 in total

1.  Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism.

Authors:  Tomás R Guilarte; Neal C Burton; Jennifer L McGlothan; Tatyana Verina; Yun Zhou; Mohab Alexander; Luu Pham; Michael Griswold; Dean F Wong; Tore Syversen; Jay S Schneider
Journal:  J Neurochem       Date:  2008-09-20       Impact factor: 5.372

2.  Effects of chronic manganese exposure on glutamatergic and GABAergic neurotransmitter markers in the nonhuman primate brain.

Authors:  Neal C Burton; Jay S Schneider; Tore Syversen; Tomás R Guilarte
Journal:  Toxicol Sci       Date:  2009-06-10       Impact factor: 4.849

3.  Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury.

Authors:  Dejan Milatovic; Ramesh C Gupta; Yingchun Yu; Snjezana Zaja-Milatovic; Michael Aschner
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-13       Impact factor: 4.219

4.  Oxidative damage and neurodegeneration in manganese-induced neurotoxicity.

Authors:  Dejan Milatovic; Snjezana Zaja-Milatovic; Ramesh C Gupta; Yingchun Yu; Michael Aschner
Journal:  Toxicol Appl Pharmacol       Date:  2009-07-14       Impact factor: 4.219

5.  Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates.

Authors:  Tomás R Guilarte; Neal C Burton; Tatyana Verina; Vinaykumar V Prabhu; Kevin G Becker; Tore Syversen; Jay S Schneider
Journal:  J Neurochem       Date:  2008-02-13       Impact factor: 5.372

6.  Manganese in human parenteral nutrition: considerations for toxicity and biomonitoring.

Authors:  Dinamene Santos; Camila Batoreu; Luisa Mateus; A P Marreilha Dos Santos; Michael Aschner
Journal:  Neurotoxicology       Date:  2013-11-01       Impact factor: 4.294

7.  Pallidal index as biomarker of manganese brain accumulation and associated with manganese levels in blood: a meta-analysis.

Authors:  Shao-Jun Li; Li Jiang; Xue Fu; Shuang Huang; Yan-Ni Huang; Xiang-Rong Li; Jing-Wen Chen; Yong Li; Hai-Lan Luo; Fang Wang; Shi-Yan Ou; Yue-Ming Jiang
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

Review 8.  "Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies".

Authors:  Tanara V Peres; Maria Rosa C Schettinger; Pan Chen; Fabiano Carvalho; Daiana S Avila; Aaron B Bowman; Michael Aschner
Journal:  BMC Pharmacol Toxicol       Date:  2016-11-04       Impact factor: 2.483

Review 9.  Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates.

Authors:  Neal C Burton; Tomás R Guilarte
Journal:  Environ Health Perspect       Date:  2008-10-03       Impact factor: 9.031

Review 10.  Evaluating the risk of manganese-induced neurotoxicity of parenteral nutrition: review of the current literature.

Authors:  Airton C Martins; Silvana Ruella Oliveira; Fernando Barbosa; Alexey A Tinkov; Anatoly V Skalny; Abel Santamaría; Eunsook Lee; Aaron B Bowman; Michael Aschner
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-03-04       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.